Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides.
AUTOR(ES)
Goodchild, J
RESUMO
Twenty different target sites within human immunodeficiency virus (HIV) RNA were selected for studies of inhibition of HIV replication by antisense oligonucleotides. Target sites were selected based on their potential capacity to block recognition functions during viral replication. Antisense oligomers complementary to sites within or near the sequence repeated at the ends of retrovirus RNA (R region) and to certain splice sites were most effective. The effect of antisense oligomer length on inhibiting virus replication was also investigated, and preliminary toxicity studies in mice show that these compounds are toxic only at high levels. The results indicate potential usefulness for these oligomers in the treatment of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex either alone or in combination with other drugs.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=281786Documentos Relacionados
- Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides
- Inhibition of influenza virus replication by phosphorothioate oligodeoxynucleotides.
- In vivo inhibition of duck hepatitis B virus replication and gene expression by phosphorothioate modified antisense oligodeoxynucleotides.
- Regiospecific inhibition of DNA duplication by antisense phosphate-methylated oligodeoxynucleotides.
- In vitro inhibition of hepatitis C virus gene expression by chemically modified antisense oligodeoxynucleotides.